Drug intelligence / Profile preview

berberine hydrochloride + bifidobacterium group

Development stage
Unknown
Lead developer
Dongbei Pharmaceutical Group
Modality
Live Biotherapeutic Products → Microbiome Therapeutics, Small Molecules
Administration
Oral
01

Overview

Berberine hydrochloride + bifidobacterium group is a combination pharmaceutical product primarily utilized for the treatment of intestinal disorders. It consists of berberine hydrochloride, an isoquinoline alkaloid with broad-spectrum antimicrobial and anti-inflammatory properties, and live *Bifidobacterium* (typically *Bifidobacterium infantis*), which serves as a probiotic. The berberine component functions by inhibiting the growth of intestinal pathogens and suppressing inflammatory pathways such as NF-κB, while the *Bifidobacterium* component helps restore the natural balance of the gut microbiota through competitive exclusion and the production of organic acids. This synergistic approach is indicated for acute and chronic diarrhea, bacterial dysentery, and gastrointestinal dysfunction resulting from intestinal dysbiosis.

Brand names
NuodikangChang Le Kang
Other names
Compound Berberine Hydrochloride and Bifidobacterium CapsulesFufang Xiaobojian Shuangqigangan JiaonangBerberine Hydrochloride and Bifidobacterium infantis
02

Targets

NF-κBDNA

Beyond the preview

Go deeper on berberine hydrochloride + bifidobacterium group.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on berberine hydrochloride + bifidobacterium group.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call